154 related articles for article (PubMed ID: 11584831)
21. A first look at the new Medicare prescription drug plans.
Frakt AB; Pizer SD
Health Aff (Millwood); 2006; 25(4):W252-61. PubMed ID: 16720588
[TBL] [Abstract][Full Text] [Related]
22. Continuing policy issues in Medicare prescription drug coverage.
Cubanski J
Issue Brief (Commonw Fund); 2004 Nov; (710):1-5. PubMed ID: 15597515
[TBL] [Abstract][Full Text] [Related]
23. Assessing Medicare prescription drug plans in four states: balancing cost and access.
Heaton E; Carino T; Dix H
Issue Brief (Commonw Fund); 2006 Aug; 22():1-14. PubMed ID: 16933399
[TBL] [Abstract][Full Text] [Related]
24. Strategies used by adults to reduce their prescription drug costs.
Cohen RA; Kirzinger WK; Gindi RM
NCHS Data Brief; 2013 Apr; (119):1-8. PubMed ID: 23742848
[TBL] [Abstract][Full Text] [Related]
25. Insurance coverage for prescription drugs: effects on use and expenditures in the Medicare population.
Lillard LA; Rogowski J; Kington R
Med Care; 1999 Sep; 37(9):926-36. PubMed ID: 10493470
[TBL] [Abstract][Full Text] [Related]
26. A sustainable future?: the role of premium subsidies in Medicare prescription drug plans.
Demchak C
Find Brief; 2007 Jan; 10(2):1-6. PubMed ID: 17302011
[No Abstract] [Full Text] [Related]
27. A Medicare prescription drug benefit: issues and options.
Cubanski J
Issue Brief (Commonw Fund); 2003 Apr; (618):1-8. PubMed ID: 12693394
[No Abstract] [Full Text] [Related]
28. Chronic conditions and disabilities: trends and issues for private drug plans.
Boccuti C; Moon M; Dowling K
Policy Brief Commonw Fund; 2003 Oct; (680):1-10. PubMed ID: 14562797
[No Abstract] [Full Text] [Related]
29. Gap in drug coverage often causes lapses in adherence to drug regimen, study shows.
Levenson D
Rep Med Guidel Outcomes Res; 2004 Sep; 15(18):9-10, 12. PubMed ID: 15452947
[No Abstract] [Full Text] [Related]
30. A Medicare prescription drug benefit: focusing on coverage and cost.
Cubanski J; Kline J
Issue Brief (Commonw Fund); 2002 Apr; (538):1-6. PubMed ID: 11993504
[No Abstract] [Full Text] [Related]
31. The new Medicare prescription-drug legislation.
Altman DE
N Engl J Med; 2004 Jan; 350(1):9-10. PubMed ID: 14702422
[No Abstract] [Full Text] [Related]
32. The Medicare Prescription Drug, Improvement, and Modernization Act of 2003.
Emmer S; Allendorf L
J Am Geriatr Soc; 2004 Jun; 52(6):1013-5. PubMed ID: 15161471
[No Abstract] [Full Text] [Related]
33. Medicare program; Medicare prescription drug discount card. Interim final rule with comment period.
Centers for Medicare & Medicaid Services (CMS), HHS
Fed Regist; 2003 Dec; 68(240):69839-927. PubMed ID: 14674398
[TBL] [Abstract][Full Text] [Related]
34. The Medicare prescription drug plan: assisting our older patients.
Klein MN
ORL Head Neck Nurs; 2004; 22(4):34-5. PubMed ID: 15617318
[TBL] [Abstract][Full Text] [Related]
35. Medicare beneficiaries and prescription drug coverage: gaps and barriers.
Gross D; Brangan N
Issue Brief (Public Policy Inst (Am Assoc Retired Pers)); 1999 Jun; (IB39):1-10. PubMed ID: 11010756
[No Abstract] [Full Text] [Related]
36. Falling into the doughnut hole: drug spending among beneficiaries with end-stage renal disease under Medicare Part D plans.
Patel UD; Davis MM
J Am Soc Nephrol; 2006 Sep; 17(9):2546-53. PubMed ID: 16855016
[TBL] [Abstract][Full Text] [Related]
37. Medicare Part D: successes and continuing challenges. Impact of Medicare Part D on Massachusetts health programs and beneficiaries.
Thomas CP; Sussman J; ;
Issue Brief (Mass Health Policy Forum); 2007 May; (32):1-32. PubMed ID: 17546802
[TBL] [Abstract][Full Text] [Related]
38. The state of the medigap market in Massachusetts.
Miller M; Turnbull N
Issue Brief (Mass Health Policy Forum); 1998 Apr; (1):1-21. PubMed ID: 12769084
[No Abstract] [Full Text] [Related]
39. Senior prescription drug coverage: the state of the medigap markets in Massachusetts and New Hampshire.
Miller M; Turnbull N
Issue Brief (Mass Health Policy Forum); 2000; (7):1-34. PubMed ID: 12769116
[No Abstract] [Full Text] [Related]
40. Who will be denied Medicare prescription drug subsidies because of the asset test?
Rice T; Desmond K
Am J Manag Care; 2006 Jan; 12(1):46-54. PubMed ID: 16402888
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
